DA01--New Contract - Polypharmacy (VA-26-00018584)
ID: 36C10B26R0004Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFTECHNOLOGY ACQUISITION CENTER NJ (36C10B)EATONTOWN, NJ, 07724, USA

NAICS

Software Publishers (513210)

PSC

IT AND TELECOM - BUSINESS APPLICATION/APPLICATION DEVELOPMENT SUPPORT SERVICES (LABOR) (DA01)
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for a new contract titled "Reducing Inappropriate Polypharmacy" to address medication management issues within the VA healthcare system. The procurement aims to develop and implement software solutions that will enhance program management, pilot phases, and sustainment of services, with an estimated total award amount of $47 million over a base period of six months and four one-year option periods. This initiative is critical for improving patient care and reducing the risks associated with polypharmacy among veterans. Interested parties must respond to the solicitation by January 14, 2026, at 10 AM Eastern Time, and can contact Contract Specialist Elena Juliano at elena.juliano@va.gov or 848-377-5194 for further information.

    Point(s) of Contact
    Elena JulianoContract Specialist
    (848) 377-5194
    elena.juliano@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs (VA) Technology Acquisition Center has issued a Combined Synopsis/Solicitation Notice (Number 36C10B26R0004) for a new contract titled "Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs." This Request for Proposal (RFP) seeks to address polypharmacy issues within the VA healthcare system. The solicitation was issued from Eatontown, NJ, with a response deadline of January 14, 2026, at 10 AM Eastern Time. The contract falls under Product Service Code DA01 and NAICS Code 513210. Key attachments include the RFP document, a Broad Agency Announcement (BAA) Agreement, and a Small Business Participation Commitment form. Elena Juliano and John Vardouniotis are the points of contact for this solicitation.
    This Business Associate Agreement (BAA) between a Business Associate and a Subcontractor outlines the requirements for handling Protected Health Information (PHI) in accordance with HIPAA and HITECH Acts, and HIPAA Rules. The agreement clarifies that the Veterans Health Administration (VHA) is the Covered Entity and owns the PHI. The Subcontractor, providing services such as data analysis or software development, will receive PHI from the Business Associate and must use or disclose it only as permitted by the agreement or law, complying with minimum necessary policies. Key obligations for the Subcontractor include implementing safeguards, notifying the Business Associate of any incidents or breaches within 24 hours, providing detailed written reports within 10 business days, mitigating harm, and ensuring any further subcontractors also adhere to these restrictions. The Subcontractor must also assist with individual requests for access, amendment, or accounting of PHI, and return or destroy all PHI upon termination of the agreement. The Business Associate agrees not to request impermissible PHI uses and to notify the Subcontractor of any restrictions or changes in privacy practices. The agreement can be amended for compliance, automatically terminates upon completion of duties, or can be terminated for cause by the Business Associate. The Subcontractor is liable for civil or criminal penalties incurred by the Covered Entity due to violations of this agreement or HIPAA Rules.
    The POLYPHARMACY SMALL BUSINESS PARTICIPATION / SUBCONTRACTING REPORT is a federal government form used to track and report small business subcontracting and participation under prime contracts. It requires companies to detail their cumulative obligated dollars and report actual participation against set goals for various small business categories, including Small Disadvantaged Business, Women-Owned Small Business, HUBZone, Veteran-Owned Small Business, and Service-Disabled Veteran-Owned Small Business. The report emphasizes cumulative dollars and percentages over the life of the contract and requires explanations for any shortfalls in proposed percentages. It also provides guidance for calculating prime and subcontracted dollars for both large and small businesses across different goals, ensuring comprehensive reporting on small business engagement.
    This Request for Proposal (RFP) 36C10B26R0004, titled “Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs,” outlines a federal contract for software and related services. The RFP, issued by the Department of Veterans Affairs, includes a base period of six months and four one-year option periods, along with two optional tasks for enterprise deployment and full capability. The contract has an estimated total award amount of $47 million.The scope of work includes program management, a pilot phase for software development and implementation, and sustainment of the solution across enterprise and optional tasks. Key deliverables include solution architecture and design, source code, implementation plans, testing scripts, VA Authority to Operate (ATO) artifacts, and various reports on outcomes, performance, and resource utilization. The contractor will be responsible for providing software license, maintenance, and technical support, with specific clauses governing these services and federal law superseding commercial license agreements. The RFP emphasizes adherence to Federal Acquisition Regulations (FAR) and VA Acquisition Regulations (VAAR), requiring offerors to have an active Federal Government contracts registration in SAM.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    DA01--Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a software solution aimed at reducing inappropriate polypharmacy among Veterans, as outlined in the presolicitation notice for Request for Information (RFI) number 36C10B25Q0550. The objective is to identify multi-drug interactions, optimize medication regimens, and support deprescribing through sophisticated, clinically-evidenced technology that adheres to VA's IT standards and ensures secure handling of patient data. This initiative is critical for improving medication management and clinical outcomes for Veterans, with a formal Request for Proposal (RFP) to be issued via Contracting Opportunities. Interested parties must ensure full registration in the System for Award Management (SAM.gov) and submit their responses by September 15, 2025, at 3 PM Eastern Time. For inquiries, contact Contract Specialist Elena Juliano at elena.juliano@va.gov or Contracting Officer John Vardouniotis at ioannis.vardouniotis@va.gov.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    DA01--State Prescription Drug Monitoring Program (PDMP) Integration Solution and Support Services - New Task Order (VA-26-00013141)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide integration solutions and sustainment support services for its State Prescription Drug Monitoring Program (PDMP) under task order VA-26-00013141. The procurement aims to maintain and enhance the existing PDMP solution, which connects VA healthcare providers to a national network of state-based PDMPs, facilitating the querying of controlled substance prescriptions. This initiative is crucial for improving patient safety and ensuring compliance with the MISSION Act Section 134. Interested vendors, particularly Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs) certified by the SBA's VetCert program, must submit their responses by January 5, 2026, at 10 AM EST, detailing their technical capabilities and experience, with a focus on the requirements outlined in the attached Request for Information documents. For further inquiries, contact Contract Specialist Edward Olivo-Cruz at Edward.Olivo-Cruz@va.gov or 848-377-5099.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    Q517--Pharmacy Emergent First Fill at the SFVAHCS
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 23, is seeking proposals for a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract for Pharmacy Emergent First Fill Services at the Sioux Falls VA Health Care System (SFVAHCS) and its associated Community-Based Outpatient Clinics (CBOCs). The contractor will be responsible for providing an open pharmacy network that allows veterans to obtain first-fill prescriptions for a maximum of 10 days (14 days for antibiotics) from the VA's Emergent Drug List, with no refills authorized and prescriptions picked up at no charge to the patients. This service is critical for ensuring timely access to necessary medications for veterans, with the contract set to begin on January 1, 2026, and extend through December 31, 2030. Interested Service-Disabled Veteran-Owned Small Business Concerns (SDVOSBC) must submit their proposals by December 26, 2025, including required documentation and licenses, to Contract Specialist Michael Wicht at michael.wicht@va.gov or by phone at 402-996-3630.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77026Q0060
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of various dosages of Duloxetine HCl capsules, intended for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. This presolicitation notice (36C77026Q0060) outlines a requirement for monthly deliveries over a three-month period, with specific quantities and packaging details for each item, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to strict delivery and packaging standards. Interested vendors must submit their quotes, including a signed SF1449, a price schedule in Excel format, and a state wholesale distributor license, by January 2, 2026, with an estimated award date of January 23, 2026. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    6515--550-26-1-985-0034 InstyMed Dispenser System (VA-26-00024776)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a limited source contract with InstyMeds for the procurement of an InstyMed Dispenser System, specifically for use at the Danville VA Medical Center and various Community-Based Outpatient Clinics (CBOCs). The VA requires four InstyMed Medication Dispensing Systems to enhance the efficiency of medication delivery from provider orders to patients, ensuring timely access to medications. This automated system is critical for pharmacy operations, offering features such as location-specific formulary management, real-time inventory tracking, and integration capabilities with existing systems like Vista, with potential for future compatibility with Cerner. For further inquiries, interested parties can contact Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4800 x43248.